Mitre Medical


Edwards Announces 6-Month Pascal Results – Eyes MitraClip Market

PARIS, May 22, 2019 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of the PASCAL … Read more

A meta-analysis of the COAPT and MITRA-FR Results changes the way we look at MR & the LV in heart failure.

Silicon Valley, December, 2018 – Proportionate and Disproportionate Functional Mitral Regurgitation A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials Paul A. Grayburn, Anna Sannino and Milton Packer Read full article here:

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Silicon Valley, September, 2018 – COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF. Physicians responded with shock and excitement to findings, but struggled to reconcile the results with the MITRA-FR trial. Read article here: Gregg W. Stone, M.D. et al. for the COAPT Investigators*